<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-C
REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ
INTERDEALER QUOTATION SYSTEM
FILED PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934 AND RULE 13a-17
OR 15 d THEREUNDER
MEDICAL TECHNOLOGY SYSTEMS,INC.
- ----------------------------------------------------------------------
(Exact name of issuer as specified in charter)
12920 AUTOMOBILE BOULEVARD, CLEARWATER, FL 34622
- ---------------------------------------------------------------------------
(Address of principal executive offices)
Issuer's telephone number, including area code (813) 576-6311
-----------------------------
I. CHANGE IN NUMBER OF SHARES OUTSTANDING
Indicate any change (increase or decrease) of 5% or more in the number of shares
outstanding:
1. Title of Security Common Stock, par value $.01
2. Number of shares outstanding before the change 3,992,832
3. Number of shares outstanding after the change 5,445,335
4. Effective date of change
5. Method of Change:
Specify method (such as merger, acquisition, exchange, distribution, stock
split, reserve split, acquisition of stock for treasury, etc.) Distribution
------------------
Give brief description of transaction: Distribution of shares pursuant
to Stock Purchase Plan.
II. CHANGE IN NAME OF ISSUER
1. Name prior to change_____________________________________________
2. Name after change________________________________________________
3. Effective date of charter amendment changing name________________
4. Date of shareholder approval of change, if required______________
<PAGE>
Date: March 15, 1996
By: /s/ Todd E. Siegel, President
--------------------------------
Todd E. Siegel, President
